PoliticalRepoPoliticalRepo

United Kingdom · Question · Written question

UIN 14334

Liraglutide

answeredUnited Kingdom· UK Parliament· EN

Introduced

16 February 2024

Last action

21 February 2024 · Answer

Status

Answered

Sponsors

Subjects

Discovery layer

Source updated

21 February 2024

Summary

To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential impact of off-label prescriptions of Victoza, Luraglutide, for the purpose of weight loss from private healthcare providers on the level of suppl

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 16 February 2024

    Written question

    To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential impact of off-label prescriptions of Victoza, Luraglutide, for the purpose of weight loss from private healthcare providers on the level of suppl

    Source: Commons

  2. 21 February 2024

    Answer

    While the position has improved, there continues to be a global supply issue with glucagon-like peptide-1 receptor agonists (GLP-1 RA), including Victoza (liraglutide). We have issued updated guidance to healthcare professionals in the form of a National ...

    Source: Written answer

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.